Cargando…

The changing faces of migraine

Detalles Bibliográficos
Autores principales:	Martelletti, Paolo, Ashina, Messoud, Edvinsson, Lars
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734366/ https://www.ncbi.nlm.nih.gov/pubmed/31077138 http://dx.doi.org/10.1186/s10194-019-1006-z

Ejemplares similares

Shaping the future of migraine targeting Calcitonin-Gene-Related-Peptide with the Disease-Modifying Migraine Drugs (DMMDs)
por: Martelletti, Paolo, et al.
Publicado: (2019)

Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
por: Ashina, Messoud, et al.
Publicado: (2018)

Targeting enkephalins and pituitary adenylate cyclase-activating polypeptide (PACAP) in migraine
por: Ashina, Messoud
Publicado: (2022)

Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
por: Bendtsen, Lars, et al.
Publicado: (2018)

Structural and Functional Brain Changes in Migraine
por: Ashina, Sait, et al.
Publicado: (2021)

European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
por: Sacco, Simona, et al.
Publicado: (2019)

Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
por: Sacco, Simona, et al.
Publicado: (2019)

CGRP in migraine
por: Tfelt-Hansen, Peer, et al.
Publicado: (2009)

The global impact of migraine
por: Martelletti, Paolo, et al.
Publicado: (2003)

Provoked versus spontaneous migraine attacks: pathophysiological similarities and differences
por: Ashina, Håkan, et al.
Publicado: (2022)

Dispute settlement understanding on the use of BOTOX(®) in chronic migraine
por: Martelletti, Paolo
Publicado: (2011)

Therapeutic novelties in migraine: new drugs, new hope?
por: Do, Thien Phu, et al.
Publicado: (2019)

The chronobiology of migraine: a systematic review
por: Poulsen, Amanda Holmen, et al.
Publicado: (2021)

The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine
por: Martelletti, Paolo
Publicado: (2018)

Correction to: Therapeutic novelties in migraine: new drugs, new hope?
por: Do, Thien Phu, et al.
Publicado: (2019)

Brain barriers and their potential role in migraine pathophysiology
por: Wiggers, Astrid, et al.
Publicado: (2022)

Menstrual migraine is caused by estrogen withdrawal: revisiting the evidence
por: Raffaelli, Bianca, et al.
Publicado: (2023)

Are indirect comparisons for treatments in migraine necessitas? Many inevitable challenges to overcome
por: Deligianni, Christina, et al.
Publicado: (2023)

The K(ATP) channel in migraine pathophysiology: a novel therapeutic target for migraine
por: Al-Karagholi, Mohammad Al-Mahdi, et al.
Publicado: (2017)

Imaging the inflammatory phenotype in migraine
por: Christensen, Rune Häckert, et al.
Publicado: (2022)

Calcitonin Gene-Related Peptide (CGRP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Migraine Pathogenesis
por: Christensen, Casper Emil, et al.
Publicado: (2022)

The role of high‐conductance calcium‐activated potassium channel in headache and migraine pathophysiology
por: Al‐Karagholi, Mohammad Al‐Mahdi, et al.
Publicado: (2022)

Reduction in the severity and duration of headache following fremanezumab treatment in patients with episodic and chronic migraine
por: Ashina, Messoud, et al.
Publicado: (2021)

Migraine aura‐like episodes following sclerotherapy for varicose veins of the lower extremities—A systematic review
por: Bahtiri, Lionesa, et al.
Publicado: (2023)

The changing comet
por: Martelletti, Paolo
Publicado: (2017)

Migraine and risk of hemorrhagic stroke: a study based on data from general practice
por: Gaist, David, et al.
Publicado: (2014)

Involvement of adenosine signaling pathway in migraine pathophysiology: a systematic review of preclinical studies
por: Thuraiaiyah, Janu, et al.
Publicado: (2022)

The Registry for Migraine (REFORM) study: methodology, demographics, and baseline clinical characteristics
por: Karlsson, William Kristian, et al.
Publicado: (2023)

The baton changed hands
por: Martelletti, Paolo
Publicado: (2021)

Cilostazol induced migraine does not respond to sumatriptan in a double blind trial
por: Falkenberg, Katrine, et al.
Publicado: (2018)

Calcitonin gene-related peptide causes migraine aura
por: Al-Khazali, Haidar M., et al.
Publicado: (2023)

Migraine induction with calcitonin gene-related peptide in patients from erenumab trials
por: Christensen, Casper Emil, et al.
Publicado: (2018)

Interrelations between migraine-like headache and persistent post-traumatic headache attributed to mild traumatic brain injury: a prospective diary study
por: Ashina, Håkan, et al.
Publicado: (2020)

Chronic headache and nitric oxide inhibitors
por: Ashina, Messoud, et al.
Publicado: (2001)

Efficacy and safety of eptinezumab in patients with migraine and self-reported aura: Post hoc analysis of PROMISE-1 and PROMISE-2
por: Ashina, Messoud, et al.
Publicado: (2022)

Erenumab prevents the occurrence of migraine attacks and not just migraine days: Post-hoc analyses of a phase III study
por: Diener, Hans-Christoph, et al.
Publicado: (2021)

Migraine and cluster headache – the common link
por: Vollesen, Anne Luise, et al.
Publicado: (2018)

Journal Citation Reports(®) 2013 tells headache experts that competitive environment has changed
por: Martelletti, Paolo
Publicado: (2014)

Diagnosis and management of migraine in ten steps
por: Eigenbrodt, Anna K., et al.
Publicado: (2021)

Debate: Are cluster headache and migraine distinct headache disorders?
por: Al-Karagholi, Mohammad Al-Mahdi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jhalhb8daug5bej48nf3fpj4r8